Chinese universities are not closing in on the West. They have already overtaken it in research.

Imperial College London reached number two globally in the QS 2026 rankings, which sounds like good news until you look at the research-specific Leiden table, where Zhejiang University is now ranked first in the world and seven or eight Chinese universities sit in the top ten, displacing positions that Harvard and Stanford held as recently as the early 2000s. China surpassed the US in share of the world's top one-percent most-cited papers in 2022, at 27.2% versus 24.9%, after a fivefold increase in scientific output between 2009 and 2021. Tsinghua and Peking are now 12th and 13th globally, up from outside the top 100 in 2018, and thirteen Chinese institutions are now in the global top 200. The mechanism is deliberate: targeted state funding into a narrow elite tier, performance incentives tied to international citations, and a strategic technology push toward a 2035 global S&T leadership target. For UK investors and businesses hiring technical talent or choosing R&D partnerships, the implication is a structural one: the research pipeline is shifting east faster than league-table headlines suggest.